According to Reuters, the FDA has stymied Neuralink’s efforts to provide a brain-computer interface that is orders of magnitude superior to what is currently available.
According to Reuters, the FDA has stymied Neuralink’s efforts to provide a brain-computer interface that is orders of magnitude superior to what is currently available.